Hologic to Present at the 2010 Morgan Stanley Global Healthcare Conference
PRNewswire-FirstCall
BEDFORD, Mass.

BEDFORD, Mass., Aug. 30, 2010 /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Rob Cascella, President and Chief Executive Officer, will present at the 2010 Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 2:45 p.m. (Eastern).

Interested parties are invited to listen to the live audio webcast of Hologic's investor presentation on the investor section of the company's website at www.hologic.com/investors-overview. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

Contact:

Deborah Gordon
Vice President, Investor Relations
Hologic, Inc.
Deborah.Gordon@hologic.com
(781) 999-7716

 

SOURCE: Hologic, Inc.